125 related articles for article (PubMed ID: 26705380)
21. Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy.
Limb GA; Soomro H; Janikoun S; Hollifield RD; Shilling J
Clin Exp Immunol; 1999 Mar; 115(3):409-14. PubMed ID: 10193411
[TBL] [Abstract][Full Text] [Related]
22. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
[TBL] [Abstract][Full Text] [Related]
23. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
[TBL] [Abstract][Full Text] [Related]
24. Elevation of serum eosinophil cationic protein, soluble tumor necrosis factor receptors and soluble intercellular adhesion molecule-1 levels in acute bronchial asthma.
Kokuludağ A; Sin A; Terzioğlu E; Saydam G; Sebik F
J Investig Allergol Clin Immunol; 2002; 12(3):211-4. PubMed ID: 12530121
[TBL] [Abstract][Full Text] [Related]
25. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
Spielmann S; Kerner T; Ahlers O; Keh D; Gerlach M; Gerlach H
Acta Anaesthesiol Scand; 2001 Mar; 45(3):364-70. PubMed ID: 11207475
[TBL] [Abstract][Full Text] [Related]
26. sTNF-RII: is it useful for the early diagnosis of rejection and for prognosis after renal transplantation?
Diller R; Winde G; Kötting S; Senninger N; Dietl KH; Spiegel HU
Transpl Int; 2002 Jul; 15(7):335-40. PubMed ID: 12122509
[TBL] [Abstract][Full Text] [Related]
27. Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-R75) receptor in humans--a possible explanation for the circadian kinetics of TNR-alpha effects.
Liebmann PM; Reibnegger G; Lehofer M; Moser M; Pürstner P; Mangge H; Schauenstein K
Int Immunol; 1998 Sep; 10(9):1393-6. PubMed ID: 9786439
[TBL] [Abstract][Full Text] [Related]
28. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD
Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
[TBL] [Abstract][Full Text] [Related]
29. The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.
Loppnow H; Werdan K; Werner C
Auton Autacoid Pharmacol; 2002 Apr; 22(2):83-92. PubMed ID: 12568125
[TBL] [Abstract][Full Text] [Related]
30. Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients.
Spoettl T; Hausmann M; Klebl F; Dirmeier A; Klump B; Hoffmann J; Herfarth H; Timmer A; Rogler G
Inflamm Bowel Dis; 2007 Jun; 13(6):727-32. PubMed ID: 17260368
[TBL] [Abstract][Full Text] [Related]
31. Increased levels of soluble tumour necrosis factor receptor-I (P55) and decreased IgG1 reactivities in HIV-1 patients with cytomegalovirus disease.
Jakobsen PH; Dodt KK; Meyer CN; Katzenstein T; Gerstoft J; Skinhøj P
Scand J Immunol; 1998 Jun; 47(6):591-5. PubMed ID: 9652828
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
[TBL] [Abstract][Full Text] [Related]
33. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
34. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
35. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.
Havlir DV; Torriani FJ; Schrier RD; Huang JY; Lederman MM; Chervenak KA; Boom WH
J Clin Microbiol; 2001 Jan; 39(1):298-303. PubMed ID: 11136787
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional role.
Corti A; Fattorini L; Thoresen OF; Ricci ML; Gallizia A; Pelagi M; Li Y; Orefici G
Infect Immun; 1999 Nov; 67(11):5762-7. PubMed ID: 10531226
[TBL] [Abstract][Full Text] [Related]
37. Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.
Goetz M; Schiel X; Heussel H; Steinmetz T; Hiddemann W; Weiss M
Eur J Med Res; 2002 Nov; 7(11):487-90. PubMed ID: 12568977
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of soluble tumor necrosis factor receptor two in plasma of HIV-seropositive individuals who use opiates.
Ryan LA; Brester M; Bohac D; Morgello S; Zheng J
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):41-5. PubMed ID: 15000697
[TBL] [Abstract][Full Text] [Related]
39. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
[TBL] [Abstract][Full Text] [Related]
40. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
